Blood storage bag with real-time purification function

By setting up a porous inner membrane layer and interlayer space on the inner wall of the blood storage bag to fill porous polysulfone-coated particles, real-time removal of biologically active substances is achieved, the problems of red blood cell storage damage and adverse reactions in blood transfusion are solved, and the quality of red blood cell storage is improved. Blood transfusion safety.

CN222092146UActive Publication Date: 2024-12-03SECOND AFFILIATED HOSPITAL ZHEJIANG UNIV COLLEGE OF MEDICINE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202420415087.8
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2024-03-04
Publication Date
2024-12-03
Estimated Expiration
2034-03-04

AI Technical Summary

Technical Problem

The damage and adverse blood transfusion reactions caused by the accumulation of biologically active substances during storage of red blood cells are lacking effective real-time clearance strategies, which affects the blood transfusion effect and the health of the blood recipient.

Method used

Design a blood storage bag with real-time purification function. The inner wall is equipped with a porous inner membrane layer and a sandwich space. The sandwich space is filled with porous polysulfone coated particles, which can remove blood metabolites in real time, such as lactic acid, pyruvate, inflammatory factors, etc. , prolong the average life span of red blood cells.

Benefits of technology

It effectively improves the storage quality of red blood cell, extends storage time, reduces the degree of red blood cell destruction and side effects after infusion, and improves blood transfusion safety.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN222092146U_ABST
    Figure CN222092146U_ABST
Patent Text Reader

Abstract

The utility model discloses a blood storage bag with a real-time purification function. The blood storage bag comprises a blood storage bag body (1), a porous inner membrane layer (2) is arranged on the inner wall of the blood storage bag body (1); an interlayer space (3) is formed between the porous inner membrane layer (2) and the inner wall of the blood storage bag body (1); and the interlayer space (3) is filled with a bioactive substance purification material. According to the blood storage bag, the influence of accumulation of various bioactive molecules on the storage quality of red blood cells can be reduced, and bioactive substances in the blood storage process are removed in real time, so that the influence of pH reduction, oxidative damage and physical damage caused by the bioactive substances on the storage quality of the red blood cells is avoided, and the storage period of the red blood cells is prolonged; the negative effect caused by a large number of bioactive substances and damaged and aged red blood cells entering the body of a blood acceptor is relieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The utility model relates to the technical field of blood storage containers, in particular to a blood storage bag with a real-time purification function. Background Art

[0002] The storage of red blood cells is necessary for adequate blood supply. However, during the storage process, red blood cells will gradually undergo physiological and biochemical changes and accumulate some potentially harmful biologically active substances. This process is called "red blood cell storage injury". Red blood cell storage injury is mainly manifested by decreased pH, decreased ATP and 2,3-DPG in red blood cells, red blood cell vesicle formation, protein and lipid oxidation, decreased S-nitrosohemoglobin, loss of cell surface sialic acid, decreased CD47 expression, phosphatidylserine eversion, and decreased red blood cell deformability, which ultimately leads to decreased red blood cell oxygen carrying capacity, easy clearance by macrophages and the occurrence of adverse transfusion reactions. A large number of studies have shown that red blood cell storage injury is closely related to the occurrence of transfusion immunosuppression. Red blood cell storage injury reduces the therapeutic effect of transfusion and may lead to an increased incidence of infection, increased tumor metastasis and recurrence, multiple organ failure, and even death of the recipient.

[0003] Red blood cell storage lesions are a major problem that plagues the field of blood transfusion. The large amount of bioactive substances produced during the storage process, on the one hand, aggravate the degree of damage to red blood cells, and on the other hand, lead to the occurrence of adverse reactions to blood transfusion. In vitro experiments have also confirmed that stored blood has an inhibitory effect on the function of immune cells and can promote tumor metastasis in tumor-bearing mice. Therefore, in-depth research on the "real-time and effective" clearance strategy of bioactive substances and the red blood cell protection mechanism is of great significance for improving the quality of red blood cell storage, reducing adverse reactions related to blood transfusion, and protecting the life and health of blood recipients.

[0004] The Chinese patent application with publication number CN109589944A discloses a porous polysulfone coated particle, a preparation method and an application thereof, and discloses a porous polysulfone coated particle, a preparation method and an application thereof. The preparation method of the porous polysulfone coated particle comprises: the present invention utilizes the adsorption of blood metabolites by adsorbent resin particles and the biocompatibility of polysulfone to prepare porous polysulfone coated particles with a "real-time removal" function, and the prepared porous polysulfone coated particles can remove blood metabolites such as lactic acid, pyruvic acid, inflammatory factors, bilirubin, immunoglobulin, complement and other medium and low molecular substances in real time, effectively prolonging the average life span of red blood cells in the blood.

[0005] At present, there is no blood storage bag with the function of "real-time removal" of biologically active substances developed at home and abroad to improve the quality of blood storage. Utility Model Content

[0006] The utility model aims to solve the technical problems existing in the above-mentioned prior art and provide a blood storage bag with real-time purification function. The blood storage bag can reduce the impact of the accumulation of various bioactive molecules on the storage quality of red blood cells, and "remove" the bioactive substances in real time during the blood storage process to avoid the impact of pH reduction, oxidative damage, and physical damage caused by bioactive substances on the storage quality of red blood cells, thereby increasing the storage period of red blood cells and reducing the negative effects caused by a large amount of bioactive substances and damaged and aged red blood cells entering the body of the blood recipient.

[0007] To achieve the above-mentioned purpose, the technical solution of the utility model is as follows: a blood storage bag with real-time purification function, comprising a blood storage bag body; the inner wall of the blood storage bag body is provided with a porous inner membrane layer; an interlayer space is formed between the porous inner membrane layer and the inner wall of the blood storage bag body; the interlayer space is filled with bioactive substance purification material.

[0008] As an optimization, the bioactive substance purification material is porous polysulfone coated particles.

[0009] As an optimization, the porous inner film layer is provided with a plurality of through holes.

[0010] As an optimization, the pore size of the through hole is smaller than the diameter of the porous polysulfone coated particles.

[0011] As an optimization, the diameter of the porous polysulfone coated particles is 5-10 mm.

[0012] Preferably, the thickness of the porous inner film layer is 0.2-0.5 mm.

[0013] The beneficial effects of the utility model are as follows: the blood storage bag of the utility model is easy to use and has a simple structure. It can remove small molecular metabolites generated during the storage of red blood cells in real time, which helps to improve the storage quality of red blood cells and prolong the storage time. Compared with red blood cells conventionally stored in the same period, the degree of red blood cell damage after transfusion is lighter and the side effects are smaller. BRIEF DESCRIPTION OF THE DRAWINGS

[0014] Figure 1 This is a front view of the blood storage bag with real-time purification function in Example 1.

[0015] Figure 2 This is a partial cross-sectional structural schematic diagram of the blood storage bag with real-time purification function in Example 1.

[0016] Figure 3 for Figure 1 Schematic diagram of the cross-sectional structure in the AA direction.

[0017] Among them, 1. blood storage bag body; 2. porous inner membrane layer; 3. interlayer space. DETAILED DESCRIPTION

[0018] The embodiments of the present invention are described in detail below, and examples of the embodiments are shown in the accompanying drawings, wherein the same or similar reference numerals throughout represent the same or similar elements or elements having the same or similar functions. The embodiments described below with reference to the accompanying drawings are exemplary and are intended to be used to explain the present invention, and should not be construed as limiting the present invention. Example

[0019] Now combined Figure 1-3 A blood storage bag with real-time purification function is described, comprising a blood storage bag body 1; the inner wall of the blood storage bag body 1 is provided with a porous inner film layer 2; an interlayer space 3 is formed between the porous inner film layer 2 and the inner wall of the blood storage bag body 1; the interlayer space 3 is filled with a bioactive substance purification material.

[0020] The bioactive substance purification material is porous polysulfone coated particles.

[0021] The porous polysulfone coated particles are prepared by the preparation method disclosed in the Chinese patent application with publication number CN109589944A. The patent application with publication number CN109589944A utilizes the adsorption of blood metabolites by adsorption resin particles and the biocompatibility of polysulfone to prepare porous polysulfone coated particles with "real-time removal" function. The prepared porous polysulfone coated particles can remove blood metabolites such as lactic acid, pyruvic acid, inflammatory factors, bilirubin, immunoglobulin, complement and other medium and low molecular substances in real time, effectively extending the average life span of red blood cells in the blood.

[0022] like Figure 2 and Figure 3 As shown, the porous inner film layer 2 is provided with a plurality of through holes.

[0023] The aperture of the through hole is smaller than the diameter of the porous polysulfone coated particle. Preferably, the aperture of the through hole is set to 1 mm. The diameter of the porous polysulfone coated particle is 5 mm.

[0024] Although the embodiments of the present invention have been shown and described above, it can be understood that the above embodiments are exemplary and cannot be understood as limitations of the present invention. Ordinary technicians in the field can change, modify, replace and modify the above embodiments within the scope of the present invention.

[0025] For those skilled in the art, various changes and modifications will undoubtedly be obvious after reading the above description. Therefore, the attached claims should be regarded as covering all changes and modifications to the true intent and scope of the utility model. Any and all equivalent ranges and contents within the scope of the claims should be considered to still be within the intent and scope of the utility model.

Claims

1. A blood storage bag with real-time purification function, comprising a blood storage bag body (1); characterized in that: The inner wall of the blood storage bag body (1) is provided with a porous inner membrane layer (2); an interlayer space (3) is formed between the porous inner membrane layer (2) and the inner wall of the blood storage bag body (1); and the interlayer space (3) is filled with a bioactive substance purification material.

2. The blood storage bag with real-time purification function according to claim 1, characterized in that: The bioactive substance purification material is porous polysulfone coated particles.

3. The blood storage bag with real-time purification function according to claim 2, characterized in that: The porous inner film layer (2) is provided with a plurality of through holes.

4. The blood storage bag with real-time purification function according to claim 3, characterized in that: The pore size of the through hole is smaller than the diameter of the porous polysulfone coated particles.

5. The blood storage bag with real-time purification function according to claim 4, characterized in that: The porous polysulfone coated particles have a diameter of 5-10 mm.

6. The blood storage bag with real-time purification function according to claim 5, characterized in that: The thickness of the porous inner film layer (2) is 0.2-0.5 mm.